Omeros reported $-1.12 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Adma Biologics USD 0.19 0.01 Mar/2026
Alnylam Pharmaceuticals USD 1.84 0.15 Jun/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Cytokinetics USD -1.5 0.17 Jun/2026
Gilead Sciences USD -6.75 8.78 Jun/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Immunic USD -0.1 0.03 Dec/2025
Insmed USD -0.06 0.7 Jun/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
MacroGenics USD -0.58 0.36 Mar/2026
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.73 0.13 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Rockwell Medical USD 0.01 0.07 Jun/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 0.64 2.52 Jun/2026
United Therapeutics USD 7.27 1.45 Jun/2026
Vertex Pharmaceuticals USD 4.73 0.26 Jun/2026